David Hollander, CMO & Global Therapeutics Lead at Revance Therapeutics, Inc. (RVNC), sold 3,908 shares at $4.17 ($16K) on 2024-11-18, disclosed to the SEC on 2024-11-19.
Open-market sale of $16k RVNC by CMO & Global Therapeutics Lead. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.